↓ Skip to main content

Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy

Overview of attention for article published in Applied Microbiology and Biotechnology, February 2006
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 8,034)
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
patent
35 patents
facebook
1 Facebook page
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
103 Dimensions

Readers on

mendeley
150 Mendeley
Title
Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy
Published in
Applied Microbiology and Biotechnology, February 2006
DOI 10.1007/s00253-005-0300-7
Pubmed ID
Authors

M. M. Harmsen, C. B. van Solt, A. M. van Zijderveld-van Bemmel, T. A. Niewold, F. G. van Zijderveld

Abstract

We previously demonstrated that oral application of the recombinant single-domain antibody fragment (VHH) clone K609, directed against Escherichia coli F4 fimbriae, reduced E. coli-induced diarrhoea in piglets, but only at high VHH doses. We have now shown that a large portion of the orally applied K609 VHH is proteolytically degraded in the stomach. Stringent selection for proteolytic stability identified seven VHHs with 7- to 138-fold increased stability after in vitro incubation in gastric fluid. By DNA shuffling we obtained four clones with a further 1.5- to 3-fold increased in vitro stability. These VHHs differed by at most ten amino acid residues from each other and K609 that were scattered over the VHH sequence and did not overlap with predicted protease cleavage sites. The most stable clone, K922, retained 41% activity after incubation in gastric fluid and 90% in jejunal fluid. Oral application of K922 to piglets confirmed its improved proteolytic stability. In addition, K922 bound to F4 fimbriae with higher affinity and inhibited fimbrial adhesion at lower VHH concentrations. K922 is thus a promising candidate for prevention of piglet diarrhoea. Furthermore, our findings could guide selection and improvement by genetic engineering of other recombinant antibody fragments for oral use.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Brazil 1 <1%
Portugal 1 <1%
Belgium 1 <1%
United Kingdom 1 <1%
Unknown 144 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 41 27%
Student > Ph. D. Student 32 21%
Student > Master 18 12%
Student > Bachelor 17 11%
Other 5 3%
Other 14 9%
Unknown 23 15%
Readers by discipline Count As %
Agricultural and Biological Sciences 49 33%
Biochemistry, Genetics and Molecular Biology 36 24%
Immunology and Microbiology 13 9%
Medicine and Dentistry 6 4%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 14 9%
Unknown 27 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#1,156,496
of 24,119,703 outputs
Outputs from Applied Microbiology and Biotechnology
#50
of 8,034 outputs
Outputs of similar age
#2,906
of 159,944 outputs
Outputs of similar age from Applied Microbiology and Biotechnology
#2
of 60 outputs
Altmetric has tracked 24,119,703 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,034 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 159,944 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.